维普中文期刊产品整合服务
40篇 您的检索式:作者名="ABRIAL C"
    题名 作者 年代 出处 被引量
1Changes and predic- tive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy显示文摘Penault-Llorca F Abrial C Raoelfils I 2008Oncologist2008,13,12:1
2Achieving higher pathological complete response rates in HER2 - positive pa- tients with induction chemotherapy without trastuzumab in operable breast cancer 显示文摘Penauh - Llorca F Abrial C Mouret - Reynier MA 2007Oncologlst2007,12,4:1
3The basis of ischemia-reperfusion and myocardial protection 显示文摘Benhabbouche S Crola da Silva C Abrial M 2011Ann FrAnesth Reanim2011,30,1:1
4Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy显示文摘TACCA O PENAULT L F ABRIAL C 2007Oncologist2007,12,:1
5Exposure to diverse antimicrobialsinduces the expression of qnrB I,qnrD and smaqnr genes by SOS-dependent regulation 显示文摘Briales ABriales A Rodriguez-Martinez J MHodriguez-Martinez JM Velasco CVelasco C 2012J Antimicrob Chemother2012,67,12:1
6Comparison of the prognostic significance of Chevallier and Sataloff' s pathologic classifications after neoadjuvant chemotherapy of operable breast cancer显示文摘Penault-Llorca F Abrial C Raoelfils I 2008Hum Pathol2008,39,8:1
7High prognostic significance of residual disease after neoadjuvant chemotherapy:a retrospective study in 710 patients with operable breast cancer显示文摘ABRIAL S C PENAULT L F DELVA R 2005Breast Cancer Res Treat2005,94,:1
8Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation显示文摘Gimbergues P Abrial C Durando X 2008Ann Surg Oncol2008,15,5:1
9Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation显示文摘Gimbergues P Abrial C Durando X 0,,05:1
10Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patientswith a clinically negative axillary nodal status at presentation 显示文摘Gimbergues P Abrial C Durando X 2008Ann Surg Oncol2008,15,5:1
11Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy显示文摘TACCA O PENAULT-LIORCA F ABRIAL C 2007Oncologist2007,12,6:1
12Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy 显示文摘Tacca O Penauh-Llorca F Abrial C 2007The Oncologist2007,12,6:1
13High prognostic significance of residual disease after neoadjuvant chemotherapy :a retrospective study in 710 patients with operable breast cancer 显示文摘Abrial S C Penault-Llorca F Delva R 2005Breast Cancer Res Treat2005,94,3:1
14Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation显示文摘Gimbergues P Abrial C Durando X 2008Ann Surg Oncol2008,15,5:1
15Cardiac fibroblasts protect cardiomyocytes against lethal ischemia- reperfusion injury 显示文摘ABRIAL M DA SILVA C C PILLOT B 2014J Mol Cell Cardiol2014,,68:1
16The basis of ischemia-reperfusion and myocardial protectional显示文摘Benhabbouche S Crola da Silva C Abrial M 2011Ann Fr Anesth Reanim2011,30,1:1
17Changes and predictive and prognostic value of the mitotic index,Ki67,cyclin D1,and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy显示文摘Penault-Llorca F Abrial C Raoelfils I 2008Oncologist2008,13,:1
18Neoadjuvant FEC 100 for operable breast cancer: eight-year experience at centre Jean perrin显示文摘Mouret R M A Abrial C J Ferriere J P 2004Clin Breast Cancer2004,5,4:1
19Achieving higher pathological complete response rates in HER2-positive patients with induction chemotherapy without trastuzumab in operable breast cancer显示文摘Penault-Liorca F Abrial C Mouret-Reynier MA 2008Oncologiat2008,12,4:1
20Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine,epirubicin,and paclitaxel as neoadjuvant treatment in patients with operable breast cancer显示文摘Abrial C Van Praagh I Delva R 2005Oncologist2005,10,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费